

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 8.88727843 |
| 2 | proline metabolic process (GO:0006560) | 6.43725227 |
| 3 | embryonic process involved in female pregnancy (GO:0060136) | 5.96563063 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.88800928 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.88800928 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.79452192 |
| 7 | DNA deamination (GO:0045006) | 5.71966529 |
| 8 | desmosome organization (GO:0002934) | 5.45595217 |
| 9 | leukocyte aggregation (GO:0070486) | 4.99655854 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.97803579 |
| 11 | transcription from mitochondrial promoter (GO:0006390) | 4.91106667 |
| 12 | negative thymic T cell selection (GO:0045060) | 4.82926351 |
| 13 | negative T cell selection (GO:0043383) | 4.82405709 |
| 14 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.79492346 |
| 15 | positive regulation of protein homooligomerization (GO:0032464) | 4.78727771 |
| 16 | establishment of apical/basal cell polarity (GO:0035089) | 4.75655875 |
| 17 | protein retention in ER lumen (GO:0006621) | 4.71766451 |
| 18 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.56707359 |
| 19 | viral transcription (GO:0019083) | 4.53955613 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 4.43031268 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.41851624 |
| 22 | GDP-mannose metabolic process (GO:0019673) | 4.41425231 |
| 23 | tolerance induction (GO:0002507) | 4.39539520 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.35074347 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.35074347 |
| 26 | hemidesmosome assembly (GO:0031581) | 4.33702679 |
| 27 | keratinization (GO:0031424) | 4.31374358 |
| 28 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.27976803 |
| 29 | oxidative demethylation (GO:0070989) | 4.24582696 |
| 30 | translational termination (GO:0006415) | 4.24231880 |
| 31 | detection of bacterium (GO:0016045) | 4.22543168 |
| 32 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.21943891 |
| 33 | protein targeting to ER (GO:0045047) | 4.12180378 |
| 34 | regulation of protein homooligomerization (GO:0032462) | 4.11454291 |
| 35 | thymic T cell selection (GO:0045061) | 4.10251288 |
| 36 | T cell selection (GO:0045058) | 4.08186418 |
| 37 | cotranslational protein targeting to membrane (GO:0006613) | 4.07154248 |
| 38 | detection of other organism (GO:0098543) | 4.05832856 |
| 39 | response to interleukin-15 (GO:0070672) | 3.99858198 |
| 40 | positive T cell selection (GO:0043368) | 3.98705378 |
| 41 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.95341126 |
| 42 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.92732515 |
| 43 | protein localization to endoplasmic reticulum (GO:0070972) | 3.85356568 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.84460610 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 3.84460610 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.84460610 |
| 47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.84460610 |
| 48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.84460610 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 3.84460610 |
| 50 | intestinal cholesterol absorption (GO:0030299) | 3.84454136 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.83933852 |
| 52 | replication fork processing (GO:0031297) | 3.83462542 |
| 53 | establishment of monopolar cell polarity (GO:0061162) | 3.83448536 |
| 54 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.83448536 |
| 55 | formation of translation preinitiation complex (GO:0001731) | 3.82545972 |
| 56 | B cell receptor signaling pathway (GO:0050853) | 3.81922579 |
| 57 | regulation of water loss via skin (GO:0033561) | 3.81455521 |
| 58 | activated T cell proliferation (GO:0050798) | 3.81096577 |
| 59 | translational elongation (GO:0006414) | 3.79674321 |
| 60 | cellular response to interleukin-15 (GO:0071350) | 3.77861486 |
| 61 | negative regulation of stress fiber assembly (GO:0051497) | 3.74776371 |
| 62 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.74660784 |
| 63 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.72884843 |
| 64 | regulation of B cell differentiation (GO:0045577) | 3.69490647 |
| 65 | molting cycle (GO:0042303) | 3.69415463 |
| 66 | hair cycle (GO:0042633) | 3.69415463 |
| 67 | establishment of skin barrier (GO:0061436) | 3.65725729 |
| 68 | neutrophil activation involved in immune response (GO:0002283) | 3.65424471 |
| 69 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.64613308 |
| 70 | ribosomal small subunit assembly (GO:0000028) | 3.61647386 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.60401719 |
| 72 | regulation of translational fidelity (GO:0006450) | 3.59473016 |
| 73 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.59320945 |
| 74 | cellular extravasation (GO:0045123) | 3.57432502 |
| 75 | regulation of integrin activation (GO:0033623) | 3.55965279 |
| 76 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.55141716 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 3.54735963 |
| 78 | Golgi transport vesicle coating (GO:0048200) | 3.54590548 |
| 79 | COPI coating of Golgi vesicle (GO:0048205) | 3.54590548 |
| 80 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.53757529 |
| 81 | positive regulation of granulocyte differentiation (GO:0030854) | 3.53110576 |
| 82 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.48024318 |
| 83 | immunoglobulin mediated immune response (GO:0016064) | 3.47421797 |
| 84 | viral life cycle (GO:0019058) | 3.45813005 |
| 85 | response to muramyl dipeptide (GO:0032495) | 3.42068166 |
| 86 | translational initiation (GO:0006413) | 3.41833779 |
| 87 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.41246938 |
| 88 | defense response to protozoan (GO:0042832) | 3.40983526 |
| 89 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.40113171 |
| 90 | T cell migration (GO:0072678) | 3.39197136 |
| 91 | response to peptidoglycan (GO:0032494) | 3.33110390 |
| 92 | mitotic G1/S transition checkpoint (GO:0044819) | 3.33061896 |
| 93 | negative regulation of phagocytosis (GO:0050765) | 3.32158984 |
| 94 | negative regulation of interleukin-6 production (GO:0032715) | 3.31480984 |
| 95 | regulation of regulatory T cell differentiation (GO:0045589) | 3.31008212 |
| 96 | neutrophil activation (GO:0042119) | 3.30188218 |
| 97 | mitochondrial DNA metabolic process (GO:0032042) | 3.30148485 |
| 98 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.28441529 |
| 99 | response to protozoan (GO:0001562) | 3.25846559 |
| 100 | sulfur amino acid catabolic process (GO:0000098) | 3.25325544 |
| 101 | regulation of tolerance induction (GO:0002643) | 3.23840521 |
| 102 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.19418883 |
| 103 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.18006345 |
| 104 | cellular response to zinc ion (GO:0071294) | 3.16442538 |
| 105 | macrophage activation involved in immune response (GO:0002281) | 3.15830362 |
| 106 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.15526371 |
| 107 | mast cell activation (GO:0045576) | 3.15466300 |
| 108 | trophectodermal cell differentiation (GO:0001829) | 3.15269989 |
| 109 | negative regulation of Ras GTPase activity (GO:0034261) | 3.14334935 |
| 110 | G1 DNA damage checkpoint (GO:0044783) | 3.13716952 |
| 111 | COPII vesicle coating (GO:0048208) | 3.13414892 |
| 112 | negative regulation of innate immune response (GO:0045824) | 3.12431394 |
| 113 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.11371739 |
| 114 | respiratory burst (GO:0045730) | 3.11128528 |
| 115 | response to type I interferon (GO:0034340) | 3.10214621 |
| 116 | negative regulation of cell cycle arrest (GO:0071157) | 3.10024178 |
| 117 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.09422813 |
| 118 | regulation of T cell tolerance induction (GO:0002664) | 3.08976541 |
| 119 | leukocyte degranulation (GO:0043299) | 3.08574927 |
| 120 | regulation of antigen processing and presentation (GO:0002577) | 3.08077801 |
| 121 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.07927369 |
| 122 | positive regulation of tolerance induction (GO:0002645) | 3.06658593 |
| 123 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05983493 |
| 124 | positive regulation of antigen processing and presentation (GO:0002579) | 3.05774111 |
| 125 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 3.05729517 |
| 126 | ribosomal small subunit biogenesis (GO:0042274) | 3.05640247 |
| 127 | embryonic placenta development (GO:0001892) | 3.05178618 |
| 128 | type I interferon signaling pathway (GO:0060337) | 3.04974615 |
| 129 | cellular response to type I interferon (GO:0071357) | 3.04974615 |
| 130 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.04674981 |
| 131 | phospholipid scrambling (GO:0017121) | 3.02516419 |
| 132 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.02209065 |
| 133 | Peyers patch development (GO:0048541) | 3.02209065 |
| 134 | dosage compensation (GO:0007549) | 3.01307769 |
| 135 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.00920667 |
| 136 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.00920667 |
| 137 | positive regulation of protein oligomerization (GO:0032461) | 3.00027602 |
| 138 | cellular protein complex disassembly (GO:0043624) | 2.98767236 |
| 139 | myeloid cell activation involved in immune response (GO:0002275) | 2.97387620 |
| 140 | regulation of mast cell degranulation (GO:0043304) | 2.96511437 |
| 141 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.96302891 |
| 142 | positive regulation by host of viral transcription (GO:0043923) | 2.95505082 |
| 143 | negative regulation of adaptive immune response (GO:0002820) | 2.95173018 |
| 144 | mRNA cleavage (GO:0006379) | 2.95011235 |
| 145 | negative regulation of interleukin-12 production (GO:0032695) | 2.94722087 |
| 146 | detection of external biotic stimulus (GO:0098581) | 2.91298891 |
| 147 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91130676 |
| 148 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.91130676 |
| 149 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.90428244 |
| 150 | keratinocyte differentiation (GO:0030216) | 2.87380322 |
| 151 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83659253 |
| 152 | granulocyte activation (GO:0036230) | 2.83409689 |
| 153 | negative regulation of protein oligomerization (GO:0032460) | 2.82957943 |
| 154 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.82509352 |
| 155 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.81777875 |
| 156 | positive regulation of histone deacetylation (GO:0031065) | 2.81439487 |
| 157 | T cell receptor signaling pathway (GO:0050852) | 2.80554160 |
| 158 | regulation of T cell mediated immunity (GO:0002709) | 2.79654578 |
| 159 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.79632479 |
| 160 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.79567607 |
| 161 | face development (GO:0060324) | 2.78565029 |
| 162 | positive regulation of interleukin-17 production (GO:0032740) | 2.78514733 |
| 163 | mast cell activation involved in immune response (GO:0002279) | 2.78246548 |
| 164 | mast cell degranulation (GO:0043303) | 2.78246548 |
| 165 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.78117929 |
| 166 | glandular epithelial cell development (GO:0002068) | 2.77632918 |
| 167 | apoptotic process involved in morphogenesis (GO:0060561) | 2.76507294 |
| 168 | base-excision repair, AP site formation (GO:0006285) | 2.73200006 |
| 169 | exocrine pancreas development (GO:0031017) | 2.73115515 |
| 170 | retinoic acid receptor signaling pathway (GO:0048384) | 2.72832634 |
| 171 | protein complex disassembly (GO:0043241) | 2.71817939 |
| 172 | anatomical structure regression (GO:0060033) | 2.71122536 |
| 173 | protein targeting to membrane (GO:0006612) | 2.70995690 |
| 174 | intestinal epithelial cell development (GO:0060576) | 2.70010460 |
| 175 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.69173167 |
| 176 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.69173167 |
| 177 | regulation of cholesterol homeostasis (GO:2000188) | 2.68226185 |
| 178 | regulation of podosome assembly (GO:0071801) | 2.67982348 |
| 179 | interferon-gamma secretion (GO:0072643) | 2.66049094 |
| 180 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.65983378 |
| 181 | multicellular organismal water homeostasis (GO:0050891) | 2.62152832 |
| 182 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.61544248 |
| 183 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.61507093 |
| 184 | regulation of protein oligomerization (GO:0032459) | 2.61105661 |
| 185 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.60598394 |
| 186 | negative regulation of JAK-STAT cascade (GO:0046426) | 2.60368820 |
| 187 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.59573433 |
| 188 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.57702176 |
| 189 | base-excision repair (GO:0006284) | 2.57381437 |
| 190 | positive regulation of lamellipodium assembly (GO:0010592) | 2.57144640 |
| 191 | activation of Rac GTPase activity (GO:0032863) | 2.55191005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.57995863 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.01378446 |
| 3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.94728327 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.94603097 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.77101359 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.76931798 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.64874569 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.61133689 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.53972328 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.26629807 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.21825900 |
| 12 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20488565 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11939318 |
| 14 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.09102892 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.08881153 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.03632824 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.01147798 |
| 18 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.93478751 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 1.92618771 |
| 20 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87296766 |
| 21 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82957030 |
| 22 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.77831969 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77765922 |
| 24 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75760837 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.74921691 |
| 26 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.73021303 |
| 27 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69693531 |
| 28 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.68216314 |
| 29 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.65962852 |
| 30 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65599340 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.65218171 |
| 32 | GATA3_26560356_Chip-Seq_TH2_Human | 1.64810453 |
| 33 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.62706585 |
| 34 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.62706585 |
| 35 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.62706585 |
| 36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61837190 |
| 37 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.61651193 |
| 38 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.61276781 |
| 39 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.61194915 |
| 40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.57649435 |
| 41 | * MAF_26560356_Chip-Seq_TH1_Human | 1.56980520 |
| 42 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.56864157 |
| 43 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56613024 |
| 44 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.54816037 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52291211 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49254201 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.48561496 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.48007116 |
| 49 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.47038152 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.46902028 |
| 51 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45099236 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.44954396 |
| 53 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39310432 |
| 54 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38482608 |
| 55 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.37992879 |
| 56 | P300_27268052_Chip-Seq_Bcells_Human | 1.37845450 |
| 57 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.37305713 |
| 58 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36895567 |
| 59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36879015 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.36370552 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36024610 |
| 62 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.33991881 |
| 63 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.33139692 |
| 64 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32332700 |
| 65 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.31341568 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30371056 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29914985 |
| 68 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29616407 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29263776 |
| 70 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.28931758 |
| 71 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.28847002 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28601557 |
| 73 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.28130848 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.27068810 |
| 75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26384674 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.25491428 |
| 77 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.24506555 |
| 78 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24315221 |
| 79 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24213460 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.24164388 |
| 81 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.23935865 |
| 82 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.21941097 |
| 83 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20436265 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.20344472 |
| 85 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20287884 |
| 86 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.19243954 |
| 87 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19203804 |
| 88 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18842442 |
| 89 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18219290 |
| 90 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16895198 |
| 91 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16292779 |
| 92 | * MAF_26560356_Chip-Seq_TH2_Human | 1.15637311 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15003583 |
| 94 | MYB_26560356_Chip-Seq_TH2_Human | 1.15002544 |
| 95 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14668225 |
| 96 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.14399099 |
| 97 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14172460 |
| 98 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.14068458 |
| 99 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.13876528 |
| 100 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13610330 |
| 101 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.13481988 |
| 102 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12771790 |
| 103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12576810 |
| 104 | P68_20966046_ChIP-Seq_HELA_Human | 1.12526804 |
| 105 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11687531 |
| 106 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11672842 |
| 107 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11435475 |
| 108 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.11247676 |
| 109 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.10960882 |
| 110 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.10881346 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09802300 |
| 112 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.09689115 |
| 113 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.09488832 |
| 114 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.09227363 |
| 115 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08832732 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08761329 |
| 117 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08050066 |
| 118 | * MYB_26560356_Chip-Seq_TH1_Human | 1.07513379 |
| 119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.07214868 |
| 120 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06955849 |
| 121 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.06805447 |
| 122 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05375400 |
| 123 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05220890 |
| 124 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05209808 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04762513 |
| 126 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04622070 |
| 127 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04570759 |
| 128 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.02697448 |
| 129 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02382836 |
| 130 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.02378828 |
| 131 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02294103 |
| 132 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00694796 |
| 133 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00557990 |
| 134 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00423101 |
| 135 | SA1_27219007_Chip-Seq_Bcells_Human | 0.99072155 |
| 136 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97979586 |
| 137 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.97613508 |
| 138 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97555447 |
| 139 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97275876 |
| 140 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.96940937 |
| 141 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96632249 |
| 142 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96201306 |
| 143 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.95737972 |
| 144 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94603630 |
| 145 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94354586 |
| 146 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92659499 |
| 147 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.92475922 |
| 148 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.92443247 |
| 149 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.92073016 |
| 150 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.92005527 |
| 151 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91967575 |
| 152 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91519101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 4.00859401 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.68506499 |
| 3 | MP0003724_increased_susceptibility_to | 3.68348037 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.23672781 |
| 5 | MP0009278_abnormal_bone_marrow | 2.99777878 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.84743792 |
| 7 | MP0002009_preneoplasia | 2.77932714 |
| 8 | MP0002419_abnormal_innate_immunity | 2.68255993 |
| 9 | MP0002452_abnormal_antigen_presenting | 2.61403590 |
| 10 | MP0000579_abnormal_nail_morphology | 2.61320508 |
| 11 | MP0005501_abnormal_skin_physiology | 2.58811290 |
| 12 | MP0002060_abnormal_skin_morphology | 2.56405154 |
| 13 | MP0003453_abnormal_keratinocyte_physiol | 2.54866671 |
| 14 | MP0003303_peritoneal_inflammation | 2.52895395 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.52863045 |
| 16 | MP0009785_altered_susceptibility_to | 2.51230408 |
| 17 | MP0000685_abnormal_immune_system | 2.47741432 |
| 18 | MP0001873_stomach_inflammation | 2.24424031 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 2.19751837 |
| 20 | MP0006082_CNS_inflammation | 2.13012486 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 2.10675387 |
| 22 | MP0005174_abnormal_tail_pigmentation | 2.07145186 |
| 23 | MP0002098_abnormal_vibrissa_morphology | 2.06282833 |
| 24 | MP0008057_abnormal_DNA_replication | 2.00896710 |
| 25 | MP0002166_altered_tumor_susceptibility | 1.98373545 |
| 26 | MP0001545_abnormal_hematopoietic_system | 1.96202305 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 1.96202305 |
| 28 | MP0004947_skin_inflammation | 1.92215639 |
| 29 | MP0001216_abnormal_epidermal_layer | 1.90599858 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 1.88000184 |
| 31 | MP0002254_reproductive_system_inflammat | 1.87349435 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.81068372 |
| 33 | MP0000467_abnormal_esophagus_morphology | 1.80979512 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.80792189 |
| 35 | MP0000490_abnormal_crypts_of | 1.80132288 |
| 36 | MP0010352_gastrointestinal_tract_polyps | 1.78745833 |
| 37 | MP0002132_abnormal_respiratory_system | 1.73146894 |
| 38 | MP0003866_abnormal_defecation | 1.69694686 |
| 39 | MP0001666_abnormal_nutrient_absorption | 1.68299499 |
| 40 | MP0002429_abnormal_blood_cell | 1.67110417 |
| 41 | MP0003941_abnormal_skin_development | 1.65981561 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.65182116 |
| 43 | MP0005275_abnormal_skin_tensile | 1.64374353 |
| 44 | MP0000470_abnormal_stomach_morphology | 1.63058851 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.62892429 |
| 46 | MP0005365_abnormal_bile_salt | 1.62748943 |
| 47 | MP0003283_abnormal_digestive_organ | 1.62040500 |
| 48 | MP0004381_abnormal_hair_follicle | 1.57342770 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.53770837 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.50323391 |
| 51 | MP0002396_abnormal_hematopoietic_system | 1.49493688 |
| 52 | MP0010771_integument_phenotype | 1.46891144 |
| 53 | * MP0005220_abnormal_exocrine_pancreas | 1.40740611 |
| 54 | MP0005310_abnormal_salivary_gland | 1.39559572 |
| 55 | MP0002006_tumorigenesis | 1.37475273 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.36668967 |
| 57 | MP0000377_abnormal_hair_follicle | 1.36416482 |
| 58 | MP0000367_abnormal_coat/_hair | 1.32450442 |
| 59 | MP0002405_respiratory_system_inflammati | 1.30849277 |
| 60 | MP0008469_abnormal_protein_level | 1.30385580 |
| 61 | MP0001851_eye_inflammation | 1.27776869 |
| 62 | MP0009931_abnormal_skin_appearance | 1.21790842 |
| 63 | MP0002933_joint_inflammation | 1.21053705 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.19228669 |
| 65 | MP0000383_abnormal_hair_follicle | 1.18163979 |
| 66 | MP0003436_decreased_susceptibility_to | 1.16496038 |
| 67 | MP0000678_abnormal_parathyroid_gland | 1.13106818 |
| 68 | MP0003300_gastrointestinal_ulcer | 1.12846805 |
| 69 | MP0008260_abnormal_autophagy | 1.12043862 |
| 70 | MP0005076_abnormal_cell_differentiation | 1.11462571 |
| 71 | MP0009764_decreased_sensitivity_to | 1.11163228 |
| 72 | MP0000762_abnormal_tongue_morphology | 1.10534720 |
| 73 | MP0010678_abnormal_skin_adnexa | 1.09546045 |
| 74 | MP0003878_abnormal_ear_physiology | 1.08645836 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 1.08645836 |
| 76 | MP0001663_abnormal_digestive_system | 1.07175840 |
| 77 | MP0000613_abnormal_salivary_gland | 1.05824117 |
| 78 | MP0005464_abnormal_platelet_physiology | 1.05274498 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 1.05078708 |
| 80 | MP0008995_early_reproductive_senescence | 1.04854340 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.02594695 |
| 82 | MP0003566_abnormal_cell_adhesion | 1.01335985 |
| 83 | MP0006072_abnormal_retinal_apoptosis | 1.01174380 |
| 84 | MP0002019_abnormal_tumor_incidence | 1.00076529 |
| 85 | MP0000477_abnormal_intestine_morphology | 0.98500186 |
| 86 | MP0002398_abnormal_bone_marrow | 0.97688160 |
| 87 | MP0005023_abnormal_wound_healing | 0.97104393 |
| 88 | MP0004233_abnormal_muscle_weight | 0.96699064 |
| 89 | MP0000703_abnormal_thymus_morphology | 0.96476251 |
| 90 | MP0000462_abnormal_digestive_system | 0.95212380 |
| 91 | MP0000858_altered_metastatic_potential | 0.94021788 |
| 92 | MP0002095_abnormal_skin_pigmentation | 0.92662584 |
| 93 | MP0003172_abnormal_lysosome_physiology | 0.92228354 |
| 94 | MP0003806_abnormal_nucleotide_metabolis | 0.92218562 |
| 95 | MP0005671_abnormal_response_to | 0.91976677 |
| 96 | MP0002249_abnormal_larynx_morphology | 0.91468016 |
| 97 | MP0000689_abnormal_spleen_morphology | 0.91337938 |
| 98 | MP0000371_diluted_coat_color | 0.90487102 |
| 99 | MP0002722_abnormal_immune_system | 0.90447164 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.90046011 |
| 101 | MP0001944_abnormal_pancreas_morphology | 0.89685234 |
| 102 | MP0001800_abnormal_humoral_immune | 0.88783904 |
| 103 | * MP0002693_abnormal_pancreas_physiology | 0.88780761 |
| 104 | MP0005085_abnormal_gallbladder_physiolo | 0.87577131 |
| 105 | MP0001340_abnormal_eyelid_morphology | 0.87542318 |
| 106 | MP0005025_abnormal_response_to | 0.86603988 |
| 107 | MP0003045_fibrosis | 0.86324284 |
| 108 | MP0001765_abnormal_ion_homeostasis | 0.85766297 |
| 109 | MP0000015_abnormal_ear_pigmentation | 0.85639638 |
| 110 | MP0003786_premature_aging | 0.84514451 |
| 111 | MP0000465_gastrointestinal_hemorrhage | 0.82580103 |
| 112 | MP0001845_abnormal_inflammatory_respons | 0.82373704 |
| 113 | MP0008961_abnormal_basal_metabolism | 0.82210097 |
| 114 | MP0002138_abnormal_hepatobiliary_system | 0.81886714 |
| 115 | MP0001191_abnormal_skin_condition | 0.79472843 |
| 116 | MP0003868_abnormal_feces_composition | 0.79350418 |
| 117 | MP0001790_abnormal_immune_system | 0.78871768 |
| 118 | MP0005387_immune_system_phenotype | 0.78871768 |
| 119 | MP0002420_abnormal_adaptive_immunity | 0.78847025 |
| 120 | MP0004808_abnormal_hematopoietic_stem | 0.77486739 |
| 121 | MP0004883_abnormal_blood_vessel | 0.76989254 |
| 122 | MP0001243_abnormal_dermal_layer | 0.76223634 |
| 123 | MP0003119_abnormal_digestive_system | 0.75913584 |
| 124 | MP0001819_abnormal_immune_cell | 0.75528792 |
| 125 | MP0002723_abnormal_immune_serum | 0.75261138 |
| 126 | MP0001849_ear_inflammation | 0.75226923 |
| 127 | MP0000716_abnormal_immune_system | 0.74583237 |
| 128 | MP0002928_abnormal_bile_duct | 0.73890758 |
| 129 | MP0003828_pulmonary_edema | 0.73720545 |
| 130 | MP0004185_abnormal_adipocyte_glucose | 0.73422740 |
| 131 | MP0003191_abnormal_cellular_cholesterol | 0.73366356 |
| 132 | MP0005367_renal/urinary_system_phenotyp | 0.73083527 |
| 133 | MP0000516_abnormal_urinary_system | 0.73083527 |
| 134 | MP0003638_abnormal_response/metabolism_ | 0.72919998 |
| 135 | MP0000647_abnormal_sebaceous_gland | 0.72356546 |
| 136 | MP0005390_skeleton_phenotype | 0.71971130 |
| 137 | MP0005083_abnormal_biliary_tract | 0.71656006 |
| 138 | MP0002998_abnormal_bone_remodeling | 0.71336259 |
| 139 | MP0004043_abnormal_pH_regulation | 0.66027273 |
| 140 | MP0004130_abnormal_muscle_cell | 0.65575379 |
| 141 | MP0001853_heart_inflammation | 0.64641773 |
| 142 | MP0009763_increased_sensitivity_to | 0.63221905 |
| 143 | MP0009765_abnormal_xenobiotic_induced | 0.61153735 |
| 144 | MP0005381_digestive/alimentary_phenotyp | 0.61119869 |
| 145 | MP0008872_abnormal_physiological_respon | 0.60663121 |
| 146 | MP0008875_abnormal_xenobiotic_pharmacok | 0.56826065 |
| 147 | MP0005166_decreased_susceptibility_to | 0.55086925 |
| 148 | MP0003943_abnormal_hepatobiliary_system | 0.54623296 |
| 149 | MP0000249_abnormal_blood_vessel | 0.52816877 |
| 150 | MP0001664_abnormal_digestion | 0.51149471 |
| 151 | MP0004510_myositis | 0.50162707 |
| 152 | MP0003075_altered_response_to | 0.48644699 |
| 153 | MP0008874_decreased_physiological_sensi | 0.48305819 |
| 154 | MP0002136_abnormal_kidney_physiology | 0.47208369 |
| 155 | MP0005535_abnormal_body_temperature | 0.47133736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.76624751 |
| 2 | Pustule (HP:0200039) | 5.27672607 |
| 3 | Hypotrichosis (HP:0001006) | 5.22479679 |
| 4 | Myositis (HP:0100614) | 5.16819216 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.58950807 |
| 6 | Stomatitis (HP:0010280) | 4.56107708 |
| 7 | Recurrent abscess formation (HP:0002722) | 4.51325141 |
| 8 | Plantar hyperkeratosis (HP:0007556) | 4.36679770 |
| 9 | Poikiloderma (HP:0001029) | 4.31291336 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 4.29387495 |
| 11 | Alopecia of scalp (HP:0002293) | 4.07416823 |
| 12 | Orchitis (HP:0100796) | 4.02393199 |
| 13 | Meningitis (HP:0001287) | 3.94263481 |
| 14 | Abnormal hemoglobin (HP:0011902) | 3.92775544 |
| 15 | Palmoplantar hyperkeratosis (HP:0000972) | 3.88812984 |
| 16 | Optic neuritis (HP:0100653) | 3.86046850 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.86046850 |
| 18 | Concave nail (HP:0001598) | 3.84511637 |
| 19 | Milia (HP:0001056) | 3.76009840 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.74981452 |
| 21 | Recurrent cutaneous fungal infections (HP:0011370) | 3.74981452 |
| 22 | Agammaglobulinemia (HP:0004432) | 3.74513146 |
| 23 | Pili torti (HP:0003777) | 3.68213643 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.65758919 |
| 25 | Palmar hyperkeratosis (HP:0010765) | 3.60505274 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.54910399 |
| 27 | Obstructive lung disease (HP:0006536) | 3.54910399 |
| 28 | Woolly hair (HP:0002224) | 3.50417895 |
| 29 | Recurrent skin infections (HP:0001581) | 3.49237176 |
| 30 | Encephalitis (HP:0002383) | 3.48013210 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 3.40344420 |
| 32 | Increased IgE level (HP:0003212) | 3.39932634 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 3.31913638 |
| 34 | Mucopolysacchariduria (HP:0008155) | 3.31407571 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.31407571 |
| 36 | Amelogenesis imperfecta (HP:0000705) | 3.29897487 |
| 37 | Lip pit (HP:0100267) | 3.29304171 |
| 38 | Prolonged bleeding time (HP:0003010) | 3.25386514 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 3.23830356 |
| 40 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.22994133 |
| 41 | Nail dystrophy (HP:0008404) | 3.14624681 |
| 42 | Fragile nails (HP:0001808) | 3.13992612 |
| 43 | Vasculitis (HP:0002633) | 3.13329054 |
| 44 | Onycholysis (HP:0001806) | 3.07521816 |
| 45 | Dysostosis multiplex (HP:0000943) | 3.04879348 |
| 46 | Recurrent viral infections (HP:0004429) | 3.03461080 |
| 47 | Increased IgM level (HP:0003496) | 3.00750247 |
| 48 | Granulocytopenia (HP:0001913) | 2.96515945 |
| 49 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.94552975 |
| 50 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.94552975 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.94552975 |
| 52 | Abnormality of T cell number (HP:0011839) | 2.94496732 |
| 53 | T lymphocytopenia (HP:0005403) | 2.94437071 |
| 54 | Erythema (HP:0010783) | 2.93498784 |
| 55 | Popliteal pterygium (HP:0009756) | 2.90768033 |
| 56 | Chest pain (HP:0100749) | 2.89869006 |
| 57 | Right ventricular cardiomyopathy (HP:0011663) | 2.86140942 |
| 58 | Premature skin wrinkling (HP:0100678) | 2.80842221 |
| 59 | Joint stiffness (HP:0001387) | 2.80797292 |
| 60 | Recurrent sinusitis (HP:0011108) | 2.79918374 |
| 61 | Turricephaly (HP:0000262) | 2.79741537 |
| 62 | Hemoptysis (HP:0002105) | 2.76912214 |
| 63 | Pulmonary infiltrates (HP:0002113) | 2.76906791 |
| 64 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.76325156 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.76190586 |
| 66 | Abnormal hair laboratory examination (HP:0003328) | 2.74683836 |
| 67 | Rib fusion (HP:0000902) | 2.72437730 |
| 68 | Leukocytosis (HP:0001974) | 2.68049594 |
| 69 | Keratoconjunctivitis (HP:0001096) | 2.67748670 |
| 70 | Cellulitis (HP:0100658) | 2.67131476 |
| 71 | Growth hormone excess (HP:0000845) | 2.67121872 |
| 72 | Basal cell carcinoma (HP:0002671) | 2.66373308 |
| 73 | Absent/shortened dynein arms (HP:0200106) | 2.64977643 |
| 74 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.64977643 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 2.63145953 |
| 76 | Squamous cell carcinoma (HP:0002860) | 2.60957803 |
| 77 | Urticaria (HP:0001025) | 2.58775494 |
| 78 | Large for gestational age (HP:0001520) | 2.55610604 |
| 79 | Severe combined immunodeficiency (HP:0004430) | 2.55141939 |
| 80 | Albinism (HP:0001022) | 2.54369750 |
| 81 | Papilloma (HP:0012740) | 2.52480407 |
| 82 | Verrucae (HP:0200043) | 2.52480407 |
| 83 | IgA deficiency (HP:0002720) | 2.51077018 |
| 84 | Nasal polyposis (HP:0100582) | 2.50272514 |
| 85 | Chronic sinusitis (HP:0011109) | 2.47874259 |
| 86 | Gastrointestinal inflammation (HP:0004386) | 2.46651601 |
| 87 | Abnormality of T cells (HP:0002843) | 2.45719268 |
| 88 | Vertebral hypoplasia (HP:0008417) | 2.45718288 |
| 89 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.45718288 |
| 90 | Ulnar bowing (HP:0003031) | 2.45702323 |
| 91 | Abnormal number of erythroid precursors (HP:0012131) | 2.45593650 |
| 92 | Abnormal blistering of the skin (HP:0008066) | 2.43340817 |
| 93 | Cheilitis (HP:0100825) | 2.43237473 |
| 94 | Inflammation of the large intestine (HP:0002037) | 2.43030802 |
| 95 | Autoimmune hemolytic anemia (HP:0001890) | 2.42392686 |
| 96 | Eosinophilia (HP:0001880) | 2.41753432 |
| 97 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.41380618 |
| 98 | Gingivitis (HP:0000230) | 2.41268641 |
| 99 | Colitis (HP:0002583) | 2.41038291 |
| 100 | Abnormality of the neuromuscular junction (HP:0003398) | 2.38341176 |
| 101 | Fatigable weakness (HP:0003473) | 2.38341176 |
| 102 | Epistaxis (HP:0000421) | 2.37033384 |
| 103 | Stomach cancer (HP:0012126) | 2.36459886 |
| 104 | Facial hemangioma (HP:0000329) | 2.36252315 |
| 105 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.35725900 |
| 106 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.35725900 |
| 107 | IgM deficiency (HP:0002850) | 2.35723733 |
| 108 | Lymphopenia (HP:0001888) | 2.34558814 |
| 109 | Short chin (HP:0000331) | 2.33789700 |
| 110 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.33365660 |
| 111 | Hypergammaglobulinemia (HP:0010702) | 2.32127244 |
| 112 | Abnormality of the nasal mucosa (HP:0000433) | 2.32127118 |
| 113 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30406989 |
| 114 | Absent thumb (HP:0009777) | 2.29977067 |
| 115 | Annular pancreas (HP:0001734) | 2.29814289 |
| 116 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.28966277 |
| 117 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.28966277 |
| 118 | Episodic fever (HP:0001954) | 2.27705635 |
| 119 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.26121894 |
| 120 | Abnormality of eosinophils (HP:0001879) | 2.25963085 |
| 121 | Bronchiectasis (HP:0002110) | 2.23645641 |
| 122 | Hypochromic anemia (HP:0001931) | 2.22774530 |
| 123 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.22565460 |
| 124 | Spontaneous hematomas (HP:0007420) | 2.22000481 |
| 125 | Sepsis (HP:0100806) | 2.21274697 |
| 126 | Dysautonomia (HP:0002459) | 2.19780092 |
| 127 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.18582815 |
| 128 | Increased cerebral lipofuscin (HP:0011813) | 2.18501880 |
| 129 | Abnormality of the pleura (HP:0002103) | 2.16571336 |
| 130 | Abnormality of B cell number (HP:0010975) | 2.14259552 |
| 131 | Arterial thrombosis (HP:0004420) | 2.14065566 |
| 132 | Abnormality of the gastric mucosa (HP:0004295) | 2.13861895 |
| 133 | Hyperparathyroidism (HP:0000843) | 2.13526183 |
| 134 | Seborrheic dermatitis (HP:0001051) | 2.13474893 |
| 135 | Pulmonary embolism (HP:0002204) | 2.10829831 |
| 136 | Bronchitis (HP:0012387) | 2.10558679 |
| 137 | Gangrene (HP:0100758) | 2.10549665 |
| 138 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10149553 |
| 139 | Orthostatic hypotension (HP:0001278) | 2.10067991 |
| 140 | Bowing of the arm (HP:0006488) | 2.09689987 |
| 141 | Bowed forearm bones (HP:0003956) | 2.09689987 |
| 142 | Skin ulcer (HP:0200042) | 2.08976608 |
| 143 | Anorexia (HP:0002039) | 2.08222540 |
| 144 | Autoimmune thrombocytopenia (HP:0001973) | 2.07432813 |
| 145 | Exocrine pancreatic insufficiency (HP:0001738) | 2.06246205 |
| 146 | Abnormal ciliary motility (HP:0012262) | 2.04681340 |
| 147 | Tongue fasciculations (HP:0001308) | 2.04387683 |
| 148 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.03067808 |
| 149 | Recurrent otitis media (HP:0000403) | 2.02375471 |
| 150 | Thrombocytosis (HP:0001894) | 2.02205648 |
| 151 | Osteomyelitis (HP:0002754) | 2.01977361 |
| 152 | Skin rash (HP:0000988) | 2.00127712 |
| 153 | Alacrima (HP:0000522) | 1.99210806 |
| 154 | Petechiae (HP:0000967) | 1.98971142 |
| 155 | Sparse scalp hair (HP:0002209) | 1.98205354 |
| 156 | Corneal erosion (HP:0200020) | 1.97996813 |
| 157 | IgG deficiency (HP:0004315) | 1.97511673 |
| 158 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.97110212 |
| 159 | Congenital hip dislocation (HP:0001374) | 1.96742293 |
| 160 | Muscle fiber atrophy (HP:0100295) | 1.96710220 |
| 161 | Abnormality of the prostate (HP:0008775) | 1.95425428 |
| 162 | Recurrent fungal infections (HP:0002841) | 1.95182344 |
| 163 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.92655956 |
| 164 | Recurrent bronchitis (HP:0002837) | 1.91660428 |
| 165 | Papilledema (HP:0001085) | 1.91398380 |
| 166 | Microcytic anemia (HP:0001935) | 1.91012931 |
| 167 | Reticulocytopenia (HP:0001896) | 1.89361467 |
| 168 | Selective tooth agenesis (HP:0001592) | 1.89328519 |
| 169 | Type I diabetes mellitus (HP:0100651) | 1.89057774 |
| 170 | Gastrointestinal dysmotility (HP:0002579) | 1.87662270 |
| 171 | Erythroderma (HP:0001019) | 1.87236396 |
| 172 | Sparse eyelashes (HP:0000653) | 1.86864814 |
| 173 | Chronic otitis media (HP:0000389) | 1.86748300 |
| 174 | Progressive neurologic deterioration (HP:0002344) | 1.86661724 |
| 175 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.84060456 |
| 176 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.83294058 |
| 177 | Vaginal fistula (HP:0004320) | 1.82927520 |
| 178 | Hypercortisolism (HP:0001578) | 1.82503236 |
| 179 | Intestinal atresia (HP:0011100) | 1.81025905 |
| 180 | Anteriorly placed anus (HP:0001545) | 1.76975463 |
| 181 | Ectropion (HP:0000656) | 1.76363719 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 4.79152571 |
| 2 | ICK | 3.70182504 |
| 3 | RIPK4 | 3.42203346 |
| 4 | MAP3K6 | 3.41860567 |
| 5 | MAP3K11 | 3.05162968 |
| 6 | PIM2 | 2.71224494 |
| 7 | FLT3 | 2.66847110 |
| 8 | MAPKAPK3 | 2.65865873 |
| 9 | ERN1 | 2.63250000 |
| 10 | DDR2 | 2.53572667 |
| 11 | IRAK4 | 2.35522204 |
| 12 | EEF2K | 2.33635668 |
| 13 | FES | 2.31913669 |
| 14 | MAP4K1 | 2.23550372 |
| 15 | DYRK1B | 2.14362366 |
| 16 | MATK | 2.11918391 |
| 17 | RPS6KB2 | 1.91780271 |
| 18 | BCKDK | 1.91133920 |
| 19 | CSK | 1.86156386 |
| 20 | TRIB3 | 1.82645446 |
| 21 | TRPM7 | 1.78130798 |
| 22 | PRKD2 | 1.74895434 |
| 23 | HIPK2 | 1.63695676 |
| 24 | PRPF4B | 1.60903199 |
| 25 | MAP3K3 | 1.58516694 |
| 26 | HCK | 1.55067496 |
| 27 | ZAP70 | 1.55028648 |
| 28 | MAP3K13 | 1.51487115 |
| 29 | PINK1 | 1.49776528 |
| 30 | SMG1 | 1.47957645 |
| 31 | FGR | 1.47942230 |
| 32 | DAPK1 | 1.44791695 |
| 33 | TYRO3 | 1.42080674 |
| 34 | MAP3K14 | 1.38568297 |
| 35 | MAP3K10 | 1.37479144 |
| 36 | CSF1R | 1.34987214 |
| 37 | SIK2 | 1.33087583 |
| 38 | PDGFRA | 1.31466531 |
| 39 | MST4 | 1.30502935 |
| 40 | MAPK11 | 1.24557597 |
| 41 | PASK | 1.21890208 |
| 42 | BTK | 1.20861481 |
| 43 | YES1 | 1.19088110 |
| 44 | PIM1 | 1.16105047 |
| 45 | LRRK2 | 1.12739172 |
| 46 | SIK3 | 1.08906879 |
| 47 | CDK7 | 1.08517991 |
| 48 | CDK6 | 1.07539174 |
| 49 | NME2 | 1.04961132 |
| 50 | JAK1 | 1.03793949 |
| 51 | BMX | 1.03313163 |
| 52 | MARK3 | 1.03274113 |
| 53 | DYRK3 | 1.02918361 |
| 54 | MAP2K3 | 1.02093372 |
| 55 | UHMK1 | 1.01180684 |
| 56 | PIK3CG | 1.00640932 |
| 57 | TYK2 | 0.98831602 |
| 58 | SIK1 | 0.98583325 |
| 59 | PKN2 | 0.96866845 |
| 60 | PRKCQ | 0.96277657 |
| 61 | RPS6KL1 | 0.95546063 |
| 62 | RPS6KC1 | 0.95546063 |
| 63 | TESK2 | 0.92711121 |
| 64 | JAK3 | 0.86698143 |
| 65 | RPS6KA6 | 0.85866554 |
| 66 | EPHA2 | 0.83448015 |
| 67 | TEC | 0.82746462 |
| 68 | CAMKK1 | 0.81281560 |
| 69 | MAP2K2 | 0.79540985 |
| 70 | KDR | 0.79200672 |
| 71 | PTK6 | 0.78871156 |
| 72 | PDK1 | 0.78770788 |
| 73 | STK10 | 0.78537360 |
| 74 | FRK | 0.77431041 |
| 75 | RIPK1 | 0.76913579 |
| 76 | NLK | 0.74757758 |
| 77 | STK11 | 0.74466642 |
| 78 | FGFR4 | 0.74159516 |
| 79 | TLK1 | 0.74083136 |
| 80 | KIT | 0.73959306 |
| 81 | BLK | 0.72760527 |
| 82 | IRAK1 | 0.71850219 |
| 83 | ITK | 0.71807298 |
| 84 | TNK2 | 0.70897487 |
| 85 | LCK | 0.70483842 |
| 86 | TBK1 | 0.69591910 |
| 87 | MST1R | 0.69332426 |
| 88 | MAPK12 | 0.65924953 |
| 89 | GSK3A | 0.65376524 |
| 90 | TXK | 0.64150916 |
| 91 | INSRR | 0.62612291 |
| 92 | PTK2B | 0.60796722 |
| 93 | CDC42BPA | 0.60567949 |
| 94 | TAOK1 | 0.59888722 |
| 95 | CDK19 | 0.58883665 |
| 96 | PTK2 | 0.58610869 |
| 97 | MAP2K6 | 0.56894384 |
| 98 | MAP3K2 | 0.56464437 |
| 99 | PRKCI | 0.54233816 |
| 100 | LYN | 0.54162520 |
| 101 | MAP3K7 | 0.54071780 |
| 102 | TAOK3 | 0.52716099 |
| 103 | MAPKAPK2 | 0.52669881 |
| 104 | PDPK1 | 0.52214445 |
| 105 | PRKG2 | 0.51622112 |
| 106 | DAPK2 | 0.48830869 |
| 107 | PRKCH | 0.48101100 |
| 108 | MAP3K1 | 0.47229598 |
| 109 | RPS6KA1 | 0.47133503 |
| 110 | MELK | 0.45658278 |
| 111 | IRAK3 | 0.45582272 |
| 112 | BMPR2 | 0.45497459 |
| 113 | FYN | 0.45207711 |
| 114 | SYK | 0.45160771 |
| 115 | GRK6 | 0.44947396 |
| 116 | EPHB1 | 0.44829350 |
| 117 | MAPK7 | 0.43975759 |
| 118 | MTOR | 0.43640391 |
| 119 | MAPK3 | 0.43106800 |
| 120 | TGFBR2 | 0.43006758 |
| 121 | IKBKB | 0.42760297 |
| 122 | IKBKE | 0.41441063 |
| 123 | STK38 | 0.41354663 |
| 124 | TGFBR1 | 0.41246770 |
| 125 | JAK2 | 0.40867055 |
| 126 | PRKAA2 | 0.40132052 |
| 127 | FGFR3 | 0.38968179 |
| 128 | PDGFRB | 0.38693561 |
| 129 | RAF1 | 0.38321162 |
| 130 | MARK2 | 0.38259475 |
| 131 | ADRBK2 | 0.37887729 |
| 132 | CAMKK2 | 0.36882402 |
| 133 | PRKAA1 | 0.36541574 |
| 134 | MAPK4 | 0.35562572 |
| 135 | NUAK1 | 0.32782961 |
| 136 | SCYL2 | 0.32070528 |
| 137 | RET | 0.31639040 |
| 138 | CHUK | 0.31427555 |
| 139 | MAP2K4 | 0.31305573 |
| 140 | CDK4 | 0.27507611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.32161605 |
| 2 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 3.49384187 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.20612314 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.17595022 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.14229232 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.12559588 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 3.03681824 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.98424128 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.81220619 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.38985479 |
| 11 | DNA replication_Homo sapiens_hsa03030 | 2.31026622 |
| 12 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.23638915 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20105195 |
| 14 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.18605172 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16243777 |
| 16 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.14794741 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 2.13199786 |
| 18 | Asthma_Homo sapiens_hsa05310 | 2.11958920 |
| 19 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.10581432 |
| 20 | Protein export_Homo sapiens_hsa03060 | 2.09777874 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.90650616 |
| 22 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.78440487 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74945380 |
| 24 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.74405567 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.62001236 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.60143932 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58840662 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.57189251 |
| 29 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.55638415 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.52149003 |
| 31 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.48031615 |
| 32 | Bladder cancer_Homo sapiens_hsa05219 | 1.44531593 |
| 33 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.44336327 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39220242 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37122882 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.36709110 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.33698970 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.32291282 |
| 39 | Thyroid cancer_Homo sapiens_hsa05216 | 1.31579216 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20085110 |
| 41 | Malaria_Homo sapiens_hsa05144 | 1.18771929 |
| 42 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12471873 |
| 43 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.10463528 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.08724830 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.08621653 |
| 46 | Adherens junction_Homo sapiens_hsa04520 | 1.05795641 |
| 47 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03889289 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.01913207 |
| 49 | Measles_Homo sapiens_hsa05162 | 0.99196117 |
| 50 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.98748522 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96485959 |
| 52 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96239633 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93988273 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92803827 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91347454 |
| 56 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.91109797 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89980833 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.89327757 |
| 59 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.87768917 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87736678 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.86889242 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.86804539 |
| 63 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86633184 |
| 64 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86491838 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86320626 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84956941 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83559689 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83550417 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83163303 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82613972 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.81339973 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.81154076 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81123829 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79599469 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78638997 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.77441498 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75603776 |
| 78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.75106720 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74628203 |
| 80 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72442913 |
| 81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.72121720 |
| 82 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71119883 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.70782695 |
| 84 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.70562173 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69327975 |
| 86 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.68385474 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68164419 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68102983 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67845001 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67546112 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67300863 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66270167 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.66136062 |
| 94 | Spliceosome_Homo sapiens_hsa03040 | 0.64710836 |
| 95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64322759 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.64290596 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63122257 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61363450 |
| 99 | Pertussis_Homo sapiens_hsa05133 | 0.60834001 |
| 100 | Phagosome_Homo sapiens_hsa04145 | 0.58921547 |
| 101 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.57832580 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54714643 |
| 103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54542486 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54449291 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53358945 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51589238 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51219278 |
| 108 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49942550 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.47482480 |
| 110 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46240755 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45998019 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.45967558 |
| 113 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.45827750 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.45028837 |
| 115 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44053268 |
| 116 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43981203 |
| 117 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42057929 |
| 118 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41590595 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.41318334 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.40975001 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40800737 |
| 122 | Leishmaniasis_Homo sapiens_hsa05140 | 0.40597542 |
| 123 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40458288 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40200733 |
| 125 | Lysosome_Homo sapiens_hsa04142 | 0.40074143 |
| 126 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39511623 |
| 127 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38814497 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.38599668 |
| 129 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37855851 |
| 130 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.37824515 |
| 131 | Colorectal cancer_Homo sapiens_hsa05210 | 0.37798687 |
| 132 | Lysine degradation_Homo sapiens_hsa00310 | 0.37729097 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36961162 |
| 134 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36775605 |
| 135 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.35865912 |
| 136 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35294613 |
| 137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.35277845 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34706389 |
| 139 | Apoptosis_Homo sapiens_hsa04210 | 0.34639687 |
| 140 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.33818176 |
| 141 | Platelet activation_Homo sapiens_hsa04611 | 0.33586020 |
| 142 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.33279637 |
| 143 | RNA transport_Homo sapiens_hsa03013 | 0.31763587 |
| 144 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30968399 |
| 145 | Influenza A_Homo sapiens_hsa05164 | 0.29770942 |
| 146 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.29060418 |
| 147 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28781663 |
| 148 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.28547449 |
| 149 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.27756733 |
| 150 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.26984611 |
| 151 | Salmonella infection_Homo sapiens_hsa05132 | 0.26019679 |
| 152 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.25547766 |

